Inovio Pharmaceuticals Inc (NASDAQ: INO) stock closed at $9.64 on 4/16/24 after a major decline of -12.3%. Moreover, above average trading volume at 147% of normal accompanied the decline. The stock has declined -15.0% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, INO is expected to continue to be Value Creation neutral.
Inovio Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Inovio Pharmaceuticals has a very low Appreciation Score of 8 but a very high Power Rating of 88, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment